Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Nanoengineered photoactive theranostic agents for cancer

View through CrossRef
Abstract Cancer has gained much attention because of slow development of advanced diagnostics and therapeutic strategies. So far, conventional procedures like surgery, radiation therapy and chemotherapy are only available options for cancer treatment which have various limitations. To overcome the limitations of conventional procedures, nanodiagnostics, and therapeutics are emerging approaches for localized diagnosis and treatment of cancer nowadays. So far, various bio‐mimicking and stimuli active cancer theranostic platforms have been established but they are limited only for animal studies and their clinical translational progress is slow. Among various cancer theranostics platforms, photoresponsive systems have shown promising outcomes for cancer theranostics applications due to their specific physicochemical properties, biocompatibility, multifunctionality etc. Moreover, these photothermal agents in combination with diagnostics probes and surface functional targeting moieties demonstrate their synergistic response for site selective imaging and ablating cancer cells/tumor. Photoactive principles are rife and with increasing access to light irradiation setups, more the discovery of photoactive products, more would be the success reaped in cancer battle. This review highlights recent developments in cancer nanotheranostics with a special focus on photoactive functional nanotheranostics. Moreover, the challenges involved in clinical translation of photoactive materials along with their application in vivid areas of cancer nanomedicine and elucidate the future implications on photoactive therapy have been addressed here.
Title: Nanoengineered photoactive theranostic agents for cancer
Description:
Abstract Cancer has gained much attention because of slow development of advanced diagnostics and therapeutic strategies.
So far, conventional procedures like surgery, radiation therapy and chemotherapy are only available options for cancer treatment which have various limitations.
To overcome the limitations of conventional procedures, nanodiagnostics, and therapeutics are emerging approaches for localized diagnosis and treatment of cancer nowadays.
So far, various bio‐mimicking and stimuli active cancer theranostic platforms have been established but they are limited only for animal studies and their clinical translational progress is slow.
Among various cancer theranostics platforms, photoresponsive systems have shown promising outcomes for cancer theranostics applications due to their specific physicochemical properties, biocompatibility, multifunctionality etc.
Moreover, these photothermal agents in combination with diagnostics probes and surface functional targeting moieties demonstrate their synergistic response for site selective imaging and ablating cancer cells/tumor.
Photoactive principles are rife and with increasing access to light irradiation setups, more the discovery of photoactive products, more would be the success reaped in cancer battle.
This review highlights recent developments in cancer nanotheranostics with a special focus on photoactive functional nanotheranostics.
Moreover, the challenges involved in clinical translation of photoactive materials along with their application in vivid areas of cancer nanomedicine and elucidate the future implications on photoactive therapy have been addressed here.

Related Results

Nanoengineered Copper: Revolutionizing Breast Cancer Care
Nanoengineered Copper: Revolutionizing Breast Cancer Care
Breast cancer continues to rank as a predominant cause of illness and death among women globally, emphasizing the critical need for innovative and effective treatment approaches. T...
Animal Models for the Evaluation of Theranostic Radiopharmaceuticals
Animal Models for the Evaluation of Theranostic Radiopharmaceuticals
Background: Theranostic is a new field of medicine that combines diagnosis and patient- specific targeted treatment. In the theranostic approach, it is aimed to detect diseased cel...
A Versatile Theranostic Nanoemulsion for Architecture‐Dependent Multimodal Imaging and Dually Augmented Photodynamic Therapy
A Versatile Theranostic Nanoemulsion for Architecture‐Dependent Multimodal Imaging and Dually Augmented Photodynamic Therapy
AbstractTo design a clinically translatable nanomedicine for photodynamic theranostics, the ingredients should be carefully considered. A high content of nanocarriers may cause ext...
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Purpose: To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods. One is to use a chemical agent like Integrin α5β1 or Oncogene C-f...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract Introduction Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
An Overview of Potential Natural Photosensitizers in Cancer Photodynamic Therapy
An Overview of Potential Natural Photosensitizers in Cancer Photodynamic Therapy
Cancer is one of the main causes of death worldwide. There are several different types of cancer recognized thus far, which can be treated by different approaches including surgery...
Abstract 5943: Development of a SMART theranostic agent for precision pancreatic cancer therapeutics
Abstract 5943: Development of a SMART theranostic agent for precision pancreatic cancer therapeutics
Abstract Pancreatic cancer is predicted to emerge as the second leading cause of cancer-related deaths in the United States by 2030. Pancreatic ductal adenocarcinoma...

Back to Top